UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 256

Sortiert nach

What is CD4+CD56+ malignancy and how should it be treated?

Bone marrow transplantation (Basingstoke), 2003-10, Vol.32 (7), p.637-646

2003

Volltextzugriff (PDF)

BCL2 Expression Is a Prognostic Marker for the Activated B-Cell–Like Type of Diffuse Large B-Cell Lymphoma

Journal of clinical oncology, 2006-02, Vol.24 (6), p.961-968

2006

Volltextzugriff (PDF)

Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases

Blood, 2012-12, Vol.120 (24), p.4795-4801

2012

Volltextzugriff (PDF)

Transformation of follicular lymphoma to diffuse large B‐cell lymphoma proceeds by distinct oncogenic mechanisms

British journal of haematology, 2007-01, Vol.136 (2), p.286-293

2007

Volltextzugriff (PDF)

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

Blood, 2004-01, Vol.103 (1), p.275-282

2004

Volltextzugriff (PDF)

Cyclin D1–negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling

Blood, 2005-12, Vol.106 (13), p.4315-4321

2005

Volltextzugriff (PDF)

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

The New England journal of medicine, 2004-11, Vol.351 (21), p.2159-2169

2004

Volltextzugriff (PDF)

The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

The New England journal of medicine, 2002-06, Vol.346 (25), p.1937-1947

2002

Volltextzugriff (PDF)

Systemic anaplastic large‐cell lymphoma: Results from the non‐Hodgkin's lymphoma classification project

American journal of hematology, 2001-07, Vol.67 (3), p.172-178

2001

Volltextzugriff (PDF)

Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival

Blood, 2006-07, Vol.108 (1), p.311-318

2006

Volltextzugriff (PDF)

Classification of non-Hodgkin lymphomas in Guatemala according to the World Health Organization system

Leukemia & lymphoma, 2011-09, Vol.52 (9), p.1681-1688

2011

Volltextzugriff (PDF)

World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997

Journal of clinical oncology, 1999-12, Vol.17 (12), p.3835-3849

1999

Volltextzugriff (PDF)

Marginal Zone B-Cell Lymphoma: A Clinical Comparison of Nodal and Mucosa-Associated Lymphoid Tissue Types

Journal of clinical oncology, 1999-08, Vol.17 (8), p.2486-2492

1999

Volltextzugriff (PDF)

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

The Journal of experimental medicine, 2003-09, Vol.198 (6), p.851-862

2003

Volltextzugriff (PDF)

Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma

Blood, 2007-12, Vol.110 (13), p.4396-4405

2007

Volltextzugriff (PDF)

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

Cancer cell, 2003-02, Vol.3 (2), p.185-197

2003

Volltextzugriff (PDF)

Use of the World Health Organization (WHO) Classification of Non-Hodgkin's Lymphoma in Mumbai, India: A Review of 200 Consecutive Cases by a Panel of Five Expert Hematopathologists

Leukemia & lymphoma, 2004-08, Vol.45 (8), p.1569-1577

2004

Volltextzugriff (PDF)

Non-Hodgkin lymphoma in Chile: a review of 207 consecutive adult cases by a panel of five expert hematopathologists

Leukemia & lymphoma, 2012-07, Vol.53 (7), p.1311-1317

2012

Volltextzugriff (PDF)

Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAIL receptor-2, predict for poor survival in diffuse large B-cell lymphoma

Blood, 2007-12, Vol.110 (13), p.4396-4405

2007

Volltextzugriff (PDF)

Classification of Non-Hodgkin Lymphoma in Seven Geographic Regions Around the World: Review of 4539 Cases from the International Non-Hodgkin Lymphoma Classification Project

Blood, 2015-12, Vol.126 (23), p.1484-1484

2015

Volltextzugriff (PDF)

Reproducibility of a of thymic epithelial his togene t ic classification tumours

Histopathology, 1995-12, Vol.27 (6), p.589-589

1995

Volltextzugriff (PDF)

Primary low-grade hepatic B-cell lymphoma of mucosa-associated lymphoid tissue (MALT)-type

The American journal of surgical pathology, 1995-05, Vol.19 (5), p.571-575

1995

Volltextzugriff (PDF)

1 – 25 von 256

Suche als RSS-Feed

Aktive Filter

ThemaPathology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(189)
Mit Volltextzugriff
(199)

Publikationsform

Artikel
(203)
Buchkapitel
(53)

Sprache

Englisch
(203)
Deutsch
(53)
Japanisch
(40)

Erscheinungsjahr

n.n

Thema

Humans
(153)
Science & Technology
(125)
Life Sciences & Biomedicine
(124)
Biological And Medical Sciences
(98)
Medical Sciences
(91)
Female
(71)
Male
(67)
Hematologic And Hematopoietic Diseases
(55)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(54)
Middle Aged
(54)
Adult
(47)
Hematology
(46)
Oncology
(46)
Aged
(43)
Animals
(39)
Mice
(26)
Adolescent
(25)
T-Lymphocytes - Immunology
(23)
Tumors
(20)
Prognosis
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

What is CD4+CD56+ malignancy and how should it be treated?

BCL2 Expression Is a Prognostic Marker for the Activated B-Cell–Like Type of Diffuse Large B-Cell Lymphoma

Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases

Transformation of follicular lymphoma to diffuse large B‐cell lymphoma proceeds by distinct oncogenic mechanisms

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

Cyclin D1–negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

Systemic anaplastic large‐cell lymphoma: Results from the non‐Hodgkin's lymphoma classification project

Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival

Classification of non-Hodgkin lymphomas in Guatemala according to the World Health Organization system

World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997

Marginal Zone B-Cell Lymphoma: A Clinical Comparison of Nodal and Mucosa-Associated Lymphoid Tissue Types

Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project

Use of the World Health Organization (WHO) Classification of Non-Hodgkin's Lymphoma in Mumbai, India: A Review of 200 Consecutive Cases by a Panel of Five Expert Hematopathologists

Non-Hodgkin lymphoma in Chile: a review of 207 consecutive adult cases by a panel of five expert hematopathologists

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions

Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAIL receptor-2, predict for poor survival in diffuse large B-cell lymphoma

Classification of Non-Hodgkin Lymphoma in Seven Geographic Regions Around the World: Review of 4539 Cases from the International Non-Hodgkin Lymphoma Classification Project

Reproducibility of a of thymic epithelial his togene t ic classification tumours

Primary low-grade hepatic B-cell lymphoma of mucosa-associated lymphoid tissue (MALT)-type

Aktive Filter

Suchergebnisse filtern